Medicare Enrolled

Dr. Sadia Ahmed, MD

Rheumatology · Williamsville, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
8207 MAIN ST STE 7&8, Williamsville, NY 14221
7166264200
In practice since 2008 (18 years)
NPI: 1558525881 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ahmed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ahmed? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ahmed

Dr. Sadia Ahmed is a rheumatology specialist in Williamsville, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Ahmed performed 1,538 Medicare services across 291 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ahmed received a total of $9,763 from 46 pharmaceutical and/or device companies across 641 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ahmed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 40% volume in NY $9,763 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,538
Medicare services
Top 40% in NY for rheumatology
291
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~85 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,020 $18 $35
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
284 $87 $175
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
133 $1 $8
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
39 $47 $150
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
39 $11 $100
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
23 $51 $140
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.5% high complexity
79.0% medium
18.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,763
Total received (2018-2024)
Avg $1,395/year across 7 years
Top 29% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
641
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,525 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$238 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,730
2023
$1,419
2022
$2,021
2021
$1,420
2020
$1,433
2019
$1,059
2018
$682

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$314
Amgen Inc.
$223
AstraZeneca Pharmaceuticals LP
$170
Janssen Biotech, Inc.
$153
E.R. Squibb & Sons, L.L.C.
$117
Inspire Medical Systems, Inc.
$109
SCILEX PHARMACEUTICALS INC.
$78
Fidia Pharma USA Inc.
$78
PFIZER INC.
$68
Kyowa Kirin, Inc.
$53
Lilly USA, LLC
$53
Aurinia Pharma U.S., Inc.
$51
Octapharma USA, Inc.
$41
UCB, Inc.
$41
Actelion Pharmaceuticals US, Inc.
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Janssen Pharmaceuticals, Inc
$23
Alexion Pharmaceuticals, Inc.
$22
Sandoz Inc.
$21
IDORSIA PHARMACEUTICALS US INC
$18
GlaxoSmithKline, LLC.
$17
Organon Llc
$9
Top 3 companies account for 40.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,090
PFIZER INC.
$1,300
Janssen Biotech, Inc.
$1,268
ABBVIE INC.
$546
AbbVie Inc.
$422
Lilly USA, LLC
$387
GlaxoSmithKline, LLC.
$386
E.R. Squibb & Sons, L.L.C.
$364
Janssen Pharmaceuticals, Inc
$332
Genentech USA, Inc.
$301
AstraZeneca Pharmaceuticals LP
$266
UCB, Inc.
$254
Horizon Therapeutics plc
$223
Boehringer Ingelheim Pharmaceuticals, Inc.
$159
GENZYME CORPORATION
$142
Inspire Medical Systems, Inc.
$109
Aurinia Pharma U.S., Inc.
$101
Janssen Scientific Affairs, LLC
$85
Alexion Pharmaceuticals, Inc.
$83
SCILEX PHARMACEUTICALS INC.
$78
Fidia Pharma USA Inc.
$78
Bausch Health US, LLC
$75
Radius Health, Inc.
$68
Celgene Corporation
$59
Kyowa Kirin, Inc.
$53
Teva Pharmaceuticals USA, Inc.
$44
Sandoz Inc.
$42
Octapharma USA, Inc.
$41
Currax Pharmaceuticals LLC
$40
Actelion Pharmaceuticals US, Inc.
$39
Gilead Sciences, Inc.
$37
Horizon Pharma plc
$30
Organon LLC
$26
Pacira Pharmaceuticals Incorporated
$24
Mallinckrodt Hospital Products Inc.
$24
Indivior Inc.
$24
Novartis Pharmaceuticals Corporation
$23
Neurocrine Biosciences, Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$18
IDORSIA PHARMACEUTICALS US INC
$18
AbbVie, Inc.
$18
Ultragenyx Pharmaceutical Inc.
$15
Bioventus LLC
$15
Sobi, Inc
$14
Neos Therapeutics, LP
$12
Organon Llc
$9
Top 3 companies account for 47.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · APLENZIN · AUSTEDO · AVSOLA · Adzenys XR-ODT · BENLYSTA · Bimzelx · CONTRAVE · COSENTYX · CYLTEZO · Cimzia · Crysvita · DALVANCE · Durolane · EVENITY · EVUSHELD · Enbrel · FORTEO · GLOPERBA · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · INFLECTRA · INGREZZA · INSPIRE · INVEGA SUSTENNA · JARDIANCE · KEVZARA · KRYSTEXXA · Kineret · LUMIZYME · LUPKYNIS · LYRICA · NEXLETOL · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · Otezla · Prolia · QUVIVIQ · RAYOS · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SPRAVATO · STELARA · STRENSIQ · SUBLOCADE · Strensiq · TALTZ · TAVNEOS · TREMFYA · TRINTELLIX · Tavneos · Tymlos · ULTOMIRIS · UZEDY · VRAYLAR · WELLBUTRIN · XELJANZ · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Williamsville?
Compare rheumatologists in the Williamsville area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
21
Per 100K population
2.2
County median income
$71,175
Nearest hospital
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
5.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ahmed is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ahmed experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Ahmed performed 1,020 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ahmed receive payments from pharmaceutical companies?
Yes. Dr. Ahmed received a total of $9,763 from 46 companies across 641 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ahmed's costs compare to other rheumatologists in Williamsville?
Dr. Ahmed's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ahmed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →